ReliOn Insulin Syringe Recalled from the Market

ReliOn Insulin Syringe – An Introduction

ReliOn Insulin Syringe is a disposable, sterile, hypodermic and single use syringe with a permanently fixed hypodermic needle. It consists of a plunger rod, single barrel and hypodermic needle fixed to the tip of the syringe.

On 5^th November 2008, the U.S. Food and Drug Administration announced a nationwide recall of wrongly labeled ReliOn Insulin syringes. Tyco Healthcare Group LP announced this recall due to the mislabeling of the dose in every syringe. This mislabeling would have resulted into the overdose delivery of insulin among the patients using it.

ReliOn Insulin Syringe is a disposable, sterile, hypodermic and single use syringe with a permanently fixed hypodermic needle. It consists of a plunger rod, single barrel and hypodermic needle fixed to the tip of the syringe. Recall was announced due to the wrong labeling of the insulin quantity in each insulin syringe. Syringes containing 100 units of U-100 insulin were patent with a label for U-40 syringe. These wrongly marked syringes could result into an overdose of this drug with the patients receiving as much as 2.5 times of the anticipated dose. This overdose could lead to serious health problems such as hypoglycemia and even death.

These wrongly labeled syringes were sold by Wal-Mart Corporation at Wal-Mart stores and Sam’s Club stores and are distributed by Can-Am Care Corp under the brand name ReliOn. Manufactures marketed 4,710 boxes of the recalled syringes thus amounting to 471,000 single syringes.

Legal Advice

Due to the serious and sometimes life threatening side effects of ReliOn, there is high possibility for the patients to receive monetary compensation. Manufacturers of ReliOn Insulin syringe recalled the wrongly labeled lot from the market. Patients who believe that they are affected by the dangers of ReliOn Insulin syringe should contact an experienced pharmaceutical lawyer who will assist in filing a lawsuit against the company.